PATENT CLAIM ANALYSIS

Application Number: 16100721
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "171000"]

Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 5):
The compound of  claim 1 , represented by one of Formulas (IIIa)-(IIIh), or a pharmaceutically acceptable salt thereof: wherein A, L, R 1 , R 2 , R 3 , and n are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 1.63265
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15216119', '15863216', '15914016', '15636424', '14830121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7905203961554079
- 35 USC 102 Novelty (BERT): 0.526656627818808
- Combined Prediction Score: 0.764134019321748
- Mean Citation Score: 320.456024
- Max Citation Score: 349.63184
- Similarity Product: 330.0877613812828

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test